Composition
- Active ingredients
- RIFAXIMIN 550MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RIFAXIMIN 550MG · TabletANDA214369-001 · Tentative approval
- RIFAXIMIN 200MG · TabletANDA214370-001 · Tentative approval
- RIFAXIMIN 550MG · TabletThis page
- RIFAXIMIN 550MG · TabletANDA208959-001 · Prescription
- RIFAXIMIN 200MG · TabletANDA220451-002 · Tentative approval
- RIFAXIMIN 200MG · TabletANDA219570-002 · Tentative approval
- RIFAXIMIN 550MG · TabletANDA213713-001 · Tentative approval
- RIFAXIMIN 200MG · TabletANDA218650-002 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA219687.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Rifaximin
- Dosage form
- Tablet
- Applicant
- Mylan Pharmaceuticals Inc
- Status
- Tentative approval
- FDA approval
- 7 Jan 2026
- Application
- ANDA219687-001